Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
9 Meters Biopharma
9 Meters Biopharma
(NMTR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Larazotide
healthy volunteers/patients
,
celiac disease
Bevifimod
stroke
,
atherosclerosis
,
intracranial arteriosclerosis
,
fallopian tube neoplasms
,
healthy volunteers/patients
,
neoplasms
,
carcinoma
,
squamous cell carcinoma
,
hypersensitivity
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
ovarian epithelial carcinoma
,
renal cell carcinoma
,
melanoma
,
peanut hypersensitivity
,
allergic rhinitis
,
rhinitis
,
basal cell carcinoma
,
squamous cell carcinoma of head and neck
,
merkel cell carcinoma
,
neoplasm metastasis
,
basal cell neoplasms
,
lung neoplasms
,
lung diseases
,
adenocarcinoma
,
adenocarcinoma of lung
,
milk hypersensitivity
,
multiple myeloma
,
plasma cell neoplasms
,
smoldering multiple myeloma
,
paraproteinemias
,
monoclonal gammopathy of undetermined significance
,
prostatic neoplasms
,
colorectal neoplasms
,
head and neck neoplasms
,
ovarian neoplasms
,
retinal diseases
,
diabetic retinopathy
,
hemorrhage
,
ascites
,
protein-losing enteropathies
,
intestinal diseases
,
myositis ossificans
,
vitreous hemorrhage
,
type 2 diabetes mellitus
,
hyperlipidemias
,
diabetes mellitus
,
macular degeneration
,
hemophilia a
,
hemophilia b
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use